Drug Shortage Report for MITOMYCIN FOR INJECTION

Last updated on 2021-10-14 History
Report ID 65987
Drug Identification Number 02230451
Brand name MITOMYCIN FOR INJECTION
Common or Proper name MITOMYCIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MITOMYCIN
Strength(s) 20MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVESICAL
Packaging size 1
ATC code L01DC
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-05-01
Actual start date 2020-05-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-10-14
Company comments Item is on suspended supply
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-10-14 French Compare
v9 2021-10-14 English Compare
v8 2020-07-10 French Compare
v7 2020-07-10 English Compare
v6 2020-07-10 English Compare
v5 2020-05-02 English Compare
v4 2019-07-29 French Compare
v3 2019-07-29 English Compare
v2 2018-11-01 French Compare
v1 2018-11-01 English Compare